Abstract:Background: It is well known that sarcopenia is a common risk factor in patients with gastrointestinal tumours, which may negatively affect the clinical outcome and prognosis. Recent studies suggest that serum creatinine-cystatin C (Cr/CysC) ratio may be associated with sarcopenia, but this association lacks sufficient evidence in patients with gastrointestinal stromal tumours (GIST). Therefore, this study aimed to investigate whether the Cr/CysC ratio was associated with sarcopenia and recurrence-free survival (RFS) in patients with GIST. Materials and methods: The study retrospectively analysed 413 patients with GIST who underwent surgical resection from January 2016 to January 2020. The serum Cr/CysC ratio was determined as a proxy for sarcopenia by comparing it with various biomarkers and Cox multifactorial analysis was used to determine the relationship between Cr/CysC ratio and prognosis. Results: Serum Cr/CysC was positively correlated with skeletal muscle area (SMA) (r = 0.256, p < 0.001), skeletal muscle index (SMI) (r = 0.300, p < 0.001), and hand grip strength (HGS) (r = 0.251, p < 0.001). The area under the receiver operator characteristic curve for sarcopenic subjects with serum Cr/CysC ratio was significantly greater than other biomarkers (Cr/CysC: 0.840, CysC: 0.732, Cr: 0.518). The optimal cut-off value for Cr/CysC was 0.65, and patients in the high Cr/CysC group had a higher 3-year recurrence-free survival (RFS) than those in the low Cr/CysC group (92.72 vs. 72.46%, p < 0.001). Cox multifactorial analysis found that the Cr/CysC ratio was an independent risk factor for RFS in GIST patients (HR = 2.143, 95% CI: 1.431-5.459, p = 0.011). Conclusion: Serum Cr/CysC ratio has satisfactory and comparable diagnostic accuracy, and prognostic value for sarcopenia in patients with GIST. Therefore, it can be a simple and practical clinical tool to screen sarcopenia in GIST patients. However, further studies are required to validate these findings.

Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.

[Serum Citrulline: a Potential Marker for Intestinal Epithelial Mass and Absorption Capacity in Short Bowel Syndrome Patients].

Serum citrulline:a potential serum marker for rejection of intestinal allograft in combined liver and small bowel transplantation in Pig

Translating plasma citrulline concentration in clinical practice: Role of cross-sectional assessment in adult patients with short bowel syndrome

Detection of intestinal permeability in cirrhotic rats using HPLC

Antenatal Growth, Gestational Age, Birth, Enteral Feeding, and Blood Citrulline Levels in Very Low Birth Weight Infants

Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells

Serum Cystatin C as a Marker of Renal Function in Critically Ill Patients With Normal Serum Creatinine

Protective effects of citrulline supplementation in ulcerative colitis rats

Characterization Of Anti-Citrinin Specific Scfvs Selected From Non-Immunized Mouse Splenocytes By Eukaryotic Ribosome Display

Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.

Plasma citrulline concentration and plasma LPS detection among critically ill patients a prospective observational study

Determination of Urinary L-Citrulline by Enzymatic Method

Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients

Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study

Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia

Simple, high-throughput measurement of gut-derived short-chain fatty acids in clinically relevant biofluids using gas chromatography-mass spectrometry

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours

S1189 Serum Protein Capillary Electrophoresis as a Biomarker for Endoscopic Disease Activity in Inflammatory Bowel Disease: A Prospective Pilot Study